Special Issue "Epilepsy and Neurodegeneration: Current Therapeutic Implications"
A special issue of Pharmaceuticals (ISSN 1424-8247).
Deadline for manuscript submissions: closed (31 December 2017)
The increasing prevalence of epilepsy and neurodegenerative disorders is a matter of global concern. Whereas epilepsy is a severe brain disorder that affects around 50 million people worldwide, neurodegenerative diseases such as Parkinson's disease (PD) and especially Alzheimer’s disease (AD) are increasing in parallel to the aging of the population in developed countries. Although current treatments with antiepileptic drugs can be effective in the control of the symptoms, one of the major problems in epilepsy treatment is the loss of drug response. The precise causes of this phenomenon, known as “refractory epilepsy”, remain to be elucidated, although a number of studies are working on this area. On another front, the currently available treatments for neurodegenerative diseases are only palliative. Therefore, the study of new synthetic and natural products, as well as alternative strategies, is of paramount importance in order to find a cure to these disorders.
Prof. Dr. Antoni Camins Espuny
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 850 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Neurological disorders